$LUCY
Innovative Eyewear Inc Stock $lucy

$lucy Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000182912624001847 Filed on March 25, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$383.5K	$615.8K	$1.152M
YoY Change	164.61%	779.64%	74.67%
Cost Of Revenue	$376.5K	$795.9K	$1.272M
YoY Change	179.67%	206.12%	77.61%
Gross Profit	$6.951K	-$180.2K	-$119.3K
YoY Change	-32.46%	-9.93%	111.99%
Gross Profit Margin	1.81%	-29.26%	-10.35%
Selling, General & Admin	$1.770M	$2.195M	$5.934M
YoY Change	41.27%	41.58%	22.21%
% of Gross Profit	25467.43%
Research & Development	$216.3K	$120.8K	$662.2K
YoY Change	43.09%	-7.05%	26.2%
% of Gross Profit	3111.8%
Depreciation & Amortization	$21.66K	$19.22K	$61.09K
YoY Change	110.14%	92.2%	176.43%
% of Gross Profit	311.6%
Operating Expenses	$2.022M	$2.315M	$6.736M
YoY Change	40.46%	37.82%	22.02%
Operating Profit	-$2.015M	-$2.496M	-$6.856M
YoY Change	40.98%	32.74%	22.93%
Interest Expense		$0.00	$3.036K
YoY Change			-97.11%
% of Operating Profit
Other Income/Expense, Net	$43.28K	$101.8K	$192.1K
YoY Change	-2423.13%		-282.67%
Pretax Income	-$1.971M	-$2.394M	-$6.663M
YoY Change	37.85%	27.33%	17.31%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$1.971M	-$2.394M	-$6.663M
YoY Change	37.78%	27.33%	17.28%
Net Earnings / Revenue	-514.07%	-388.75%	-578.18%
Basic Earnings Per Share	-$0.15		-$0.63
Diluted Earnings Per Share	-$0.15	-$0.18	-$0.63
COMMON SHARES
Basic Shares Outstanding	12.93M shares	12.92M shares
Diluted Shares Outstanding	12.95M shares		10.52M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.649M	$4.287M	$4.287M
YoY Change	-23.23%	19.43%	19.43%
Cash & Equivalents	$2.649M	$4.287M	$4.287M
Short-Term Investments
Other Short-Term Assets	$59.45K	$59.45K	$702.9K
YoY Change	64.04%	64.04%	56.19%
Inventory	$858.9K	$533.2K	$533.2K
Prepaid Expenses	$425.9K	$313.6K
Receivables	$52.78K	$93.21K	$93.21K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.111M	$5.617M	$5.617M
YoY Change	-9.5%	32.45%	32.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$143.5K	$132.8K	$132.9K
YoY Change	4.3%	10.94%	10.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$118.5K	$72.64K	$72.64K
YoY Change	43.21%	-11.17%	-9.2%
Total Long-Term Assets	$702.2K	$602.0K	$602.0K
YoY Change	23.02%	34.03%	33.78%
TOTAL ASSETS
Total Short-Term Assets	$4.111M	$5.617M	$5.617M
Total Long-Term Assets	$702.2K	$602.0K	$602.0K
Total Assets	$4.813M	$6.219M	$6.219M
YoY Change	-5.87%	32.6%	32.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$841.0K	$582.0K	$582.0K
YoY Change	190.0%	107.85%	107.85%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$883.5K	$624.5K	$624.5K
YoY Change	75.07%	4.08%	4.08%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$27.95K	$35.45K	$35.45K
YoY Change	-53.42%	-49.36%	-49.36%
Total Long-Term Liabilities	$27.95K	$35.45K	$35.45K
YoY Change	-53.42%	-49.36%	-49.36%
TOTAL LIABILITIES
Total Short-Term Liabilities	$883.5K	$624.5K	$624.5K
Total Long-Term Liabilities	$27.95K	$35.45K	$35.45K
Total Liabilities	$911.4K	$659.9K	$659.9K
YoY Change	62.01%	-0.83%	-1.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$18.94M	-$16.97M
YoY Change	61.38%	64.66%
Common Stock	$132.00	$129.00
YoY Change	71.43%	76.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.902M	$5.559M	$5.559M
YoY Change
Total Liabilities & Shareholders Equity	$4.813M	$6.219M	$6.219M
YoY Change	-5.87%	32.6%	32.6%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$1.971M	-$2.394M	-$6.663M
YoY Change	37.78%	27.33%	17.28%
Depreciation, Depletion And Amortization	$21.66K	$19.22K	$61.09K
YoY Change	110.14%	92.2%	176.43%
Cash From Operating Activities	-$1.467M	-$1.136M	-$5.766M
YoY Change	2.82%	-6.89%	78.83%
INVESTING ACTIVITIES
Capital Expenditures	$32.30K	-$7.970K	$78.46K
YoY Change	14.8%	-113.28%	-35.45%
Acquisitions
YoY Change
Other Investing Activities	-$11.66K	$2.002M	$52.75K
YoY Change
Cash From Investing Activities	-$95.54K	$2.010M	-$198.8K
YoY Change	-30.24%	-3449.88%	-9.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$75.99K	-490.2K	$6.661M
YoY Change	-105.34%	444.63%	-4.23%
NET CHANGE
Cash From Operating Activities	-$1.467M	-1.136M	-$5.766M
Cash From Investing Activities	-$95.54K	2.010M	-$198.8K
Cash From Financing Activities	-$75.99K	-490.2K	$6.661M
Net Change In Cash	-$1.639M	383.8K	$696.3K
YoY Change	1060.02%	-128.01%	-80.17%
FREE CASH FLOW
Cash From Operating Activities	-$1.467M	-$1.136M	-$5.766M
Capital Expenditures	$32.30K	-$7.970K	$78.46K
Free Cash Flow	-$1.500M	-$1.128M	-$5.845M
YoY Change	3.05%	-11.87%	74.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001808377
CY2022Q4	LUCY	Due From Tekcapital And Affiliates DueFromTekcapitalAndAffiliates		usd
CY2023Q4	LUCY	Due To Parent And Affiliates DueToParentAndAffiliates		usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2022	LUCY	Writeoff Of Uncollectible Stock Subscription Receivable WriteoffOfUncollectibleStockSubscriptionReceivable		usd
CY2022	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss		usd
CY2022	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets		usd
CY2022	LUCY	Purchases Of Debt Securities PurchasesOfDebtSecurities		usd
CY2022	LUCY	Proceeds From Redemption Of Debt Securities ProceedsFromRedemptionOfDebtSecurities		usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	LUCY	Proceeds From Second Public Offering ProceedsFromSecondPublicOffering		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2023	LUCY	Collection Of Stock Subscription Receivable CollectionOfStockSubscriptionReceivable		usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022	LUCY	Repayment Of Amounts Due To Tekcapital And Affiliates RepaymentOfAmountsDueToTekcapitalAndAffiliates		usd
CY2023	LUCY	Writeoff Of Uncollectible Stock Subscription Receivables WriteoffOfUncollectibleStockSubscriptionReceivables		usd
CY2023	LUCY	Issuance Of Shares From Conversion Of Related Party Convertible Debt IssuanceOfSharesFromConversionOfRelatedPartyConvertibleDebt		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	6916698	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12933544	shares
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Name AuditorName	Cherry Bekaert LLP
CY2023	dei	Auditor Firm AuditorFirmId	677
CY2023	dei	Auditor Location AuditorLocation	Tampa, Florida
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4287447	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3591109	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	25772	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	92646	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	93211	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	110258	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	313648	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	210673	usd
CY2023Q4	LUCY	Inventory Prepayment InventoryPrepayment	323520	usd
CY2022Q4	LUCY	Inventory Prepayment InventoryPrepayment	197750	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	533239	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	94701	usd
CY2023Q4	LUCY	Due From Tekcapital And Affiliates DueFromTekcapitalAndAffiliates	6256	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	59447	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	36240	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	5616768	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4240731	usd
CY2023Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	286429	usd
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	137557	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	110073	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	110073	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	132848	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	119744	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	72644	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	81779	usd
CY2023Q4	us-gaap	Assets Assets	6218762	usd
CY2022Q4	us-gaap	Assets Assets	4689884	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	581986	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	275660	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	42500	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	30000	usd
CY2022Q4	LUCY	Due To Parent And Affiliates DueToParentAndAffiliates	232989	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	61356	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	624486	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	600005	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	35450	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	65450	usd
CY2023Q4	us-gaap	Liabilities Liabilities	659936	usd
CY2022Q4	us-gaap	Liabilities Liabilities	665455	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12917239	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12917239	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7307157	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7307157	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	129	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	73	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	22528112	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14330343	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16969415	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10305987	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	5558826	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4024429	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6218762	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4689884	usd
CY2023	us-gaap	Revenues Revenues	1152479	usd
CY2022	us-gaap	Revenues Revenues	659788	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	1271808	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	716077	usd
CY2023	us-gaap	Gross Profit GrossProfit	-119329	usd
CY2022	us-gaap	Gross Profit GrossProfit	-56289	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3886960	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2796669	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2047069	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2059012	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	662184	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	524692	usd
CY2022	us-gaap	Management Fee Expense ManagementFeeExpense	140000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	195150	usd
CY2023	us-gaap	Interest Expense InterestExpense	3036	usd
CY2022	us-gaap	Interest Expense InterestExpense	105171	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	192114	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-105171	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-6663428	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5681833	usd
CY2023	LUCY	Weighted Average Number Of Shares Outstanding WeightedAverageNumberOfSharesOutstanding	10515995	shares
CY2022	LUCY	Weighted Average Number Of Shares Outstanding WeightedAverageNumberOfSharesOutstanding	6528959	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.63
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.87
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.87
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4024429	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	17650	usd
CY2023	LUCY	Exercises Of Warrants By Stockholders ExercisesOfWarrantsByStockholders	2736450	usd
CY2023	LUCY	Second Public Offering SecondPublicOffering	4115688	usd
CY2023	LUCY	Exercises Of Warrants Related To Private Placement Transaction ExercisesOfWarrantsRelatedToPrivatePlacementTransaction	391268	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	936769	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6663428	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	5558826	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	207516	usd
CY2022	LUCY	Collection Of Stock Subscription Receivables CollectionOfStockSubscriptionReceivables	6684	usd
CY2022	LUCY	Initial Public Offering InitialPublicOffering	6015918	usd
CY2022	LUCY	Shares Issued For Conversion Of Related Party Convertible Note SharesIssuedForConversionOfRelatedPartyConvertibleNote	2002280	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1473864	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5681833	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4024429	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6663428	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5681833	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	61093	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22101	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	24164	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10466	usd
CY2023	us-gaap	Other Noncash Expense OtherNoncashExpense	3036	usd
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense	105171	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	936769	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1473864	usd
CY2023	LUCY	Expenses Paid By Parent And Affiliates ExpensesPaidByParentAndAffiliates	299061	usd
CY2022	LUCY	Expenses Paid By Parent And Affiliates ExpensesPaidByParentAndAffiliates	960362	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-14725	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	116230	usd
CY2023	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	50796	usd
CY2023	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-2316	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3678	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	183094	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	303290	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	67951	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	102975	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	142292	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	564308	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-47765	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-1460	usd
CY2023	LUCY	Contract Assets And Liabilities ContractAssetsAndLiabilities	-3878	usd
CY2022	LUCY	Contract Assets And Liabilities ContractAssetsAndLiabilities	22569	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5766303	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3224418	usd
CY2023	LUCY	Purchases Of Debt Securities PurchasesOfDebtSecurities	1949204	usd
CY2023	LUCY	Proceeds From Redemption Of Debt Securities ProceedsFromRedemptionOfDebtSecurities	-2000000	usd
CY2023	LUCY	Payment To Acquire Patent Costs PaymentToAcquirePatentCosts	173036	usd
CY2022	LUCY	Payment To Acquire Patent Costs PaymentToAcquirePatentCosts	60717	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	78463	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	121561	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1950	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	37673	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-198753	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-219951	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	6127067	usd
CY2023	LUCY	Proceeds From Second Public Offering ProceedsFromSecondPublicOffering	4115688	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3127718	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	17650	usd
CY2022	LUCY	Collection Of Stock Subscription Receivable CollectionOfStockSubscriptionReceivable	6684	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1475000	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	109499	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	653000	usd
CY2023	LUCY	Repayment Of Amounts Due To Tekcapital And Affiliates RepaymentOfAmountsDueToTekcapitalAndAffiliates	490163	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6661394	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6955751	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	696338	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	3511382	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3591109	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	79727	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4287447	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3591109	usd
CY2023	LUCY	Expenses Paid For By Parent Reported As Increase In Due To Parent And Affiliates And Related Party Convertible Debt ExpensesPaidForByParentReportedAsIncreaseInDueToParentAndAffiliatesAndRelatedPartyConvertibleDebt	299061	usd
CY2022	LUCY	Expenses Paid For By Parent Reported As Increase In Due To Parent And Affiliates And Related Party Convertible Debt ExpensesPaidForByParentReportedAsIncreaseInDueToParentAndAffiliatesAndRelatedPartyConvertibleDebt	960362	usd
CY2022	LUCY	Writeoff Of Uncollectible Stock Subscription Receivables WriteoffOfUncollectibleStockSubscriptionReceivables	-4542	usd
CY2022	LUCY	Issuance Of Shares From Conversion Of Related Party Convertible Debt IssuanceOfSharesFromConversionOfRelatedPartyConvertibleDebt	2002280	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_801_eus-gaap--NatureOfOperations_z0I8L62kMlz1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 1 – <span id="xdx_82C_zlkT44dPoEj2">GENERAL INFORMATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Innovative Eyewear, Inc. (the “Company,” “us,” “we,” or “our”) is a corporation organized under the laws of the State of Florida that develops and sells cutting-edge eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The Company was founded by Lucyd Ltd., a portfolio company of Tekcapital Plc through Tekcapital Europe, Ltd. (collectively, together with Lucyd Ltd., “Tekcapital and Affiliates”), which owned approximately 40% of our issued and outstanding shares of common stock and was our largest stockholder as of December 31, 2023. Innovative Eyewear licensed the exclusive rights to the Lucyd® brand from Lucyd Ltd., which includes the exclusive use of all of Lucyd’s intellectual property, including our main product, Lucyd Lyte® glasses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zH5jdsro4XT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86F_zlUvNusBbyXj">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, particularly given the significant uncertainties associated with the current geopolitical and economic environment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023	LUCY	Bad Debt Expenses BadDebtExpenses	30275	usd
CY2022	LUCY	Bad Debt Expenses BadDebtExpenses	116230	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	92646	usd
CY2023	LUCY	Bad Debt Expense BadDebtExpense	30275	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	52149	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	45000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	25772	usd
CY2023Q4	LUCY	Inventory Prepayment InventoryPrepayment	323520	usd
CY2022Q4	LUCY	Inventory Prepayment InventoryPrepayment	197750	usd
CY2023	us-gaap	Depreciation Depreciation	61093	usd
CY2022	us-gaap	Depreciation Depreciation	22101	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	213825	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	142343	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	80977	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22599	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	132848	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	119744	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_z8D9jot0M2Gh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86A_zSOaHs6U9LBk">Concentrations of Credit Risk</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, and accounts receivable. The Company limits its credit risk with respect to cash by maintaining cash and cash equivalent balances with high quality financial institutions. At times, the Company’s cash balances may exceed federally insured limits. Concentrations of credit risk with respect to accounts receivable are generally considered minimal due to collection history. However, as of December 31, 2023, $<span id="xdx_90C_eus-gaap--AccountsReceivableNetCurrent_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_pp0p0" title="Accounts receivable">77,950</span> or approximately <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SingleCustomerMember_pdd" title="Concentrations of Credit Risk">50%</span> of the Company’s gross accounts receivable balance was related to a single customer under a long-term instalment arrangement; the Company manages its risk related to this counterparty via other contractual arrangements with such counterparty, and incentivization through stock-based compensation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023	LUCY	Revenue Recognized RevenueRecognized	17500	usd
CY2023Q4	LUCY	Allowance For Sales Returns AllowanceForSalesReturns	25933	usd
CY2022Q4	LUCY	Allowance For Sales Returns AllowanceForSalesReturns	24897	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1389526	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1193185	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	50907	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	35149	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1440433	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1228334	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	24164	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	10466	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	877645	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	610530	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	219723	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	122133	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	2483530	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	1346823	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	148177	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	81911	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3729075	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2161397	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3729075	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2161397	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	11826332	usd
CY2023Q4	LUCY	State Net Operating Loss Carryforwards StateNetOperatingLossCarryforwards	6515176	usd
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	329232	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	156196	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-42803	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-18639	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	286429	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	137557	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	30000	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	61356	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	48143	usd
CY2023Q4	LUCY	Legal Matters Liability LegalMattersLiability	103000	usd
CY2023	LUCY	Base Term BaseTerm	P10Y
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	161210	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	436000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	834000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1290000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1543000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	9907000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	14171210	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	LUCY	Number Of Warrant Exercised NumberOfWarrantExercised	408600	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.75
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1532250	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6413080	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1800500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.61
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2332500	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.61
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2332500	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y8M4D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.61
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2332500	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.92
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1153000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.01
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	316000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.94
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	275000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.08
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2894500	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y2M19D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.39
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1795219	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y4M24D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.49
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.84
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	721000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y1M13D
CY2023Q2	LUCY	Number Of Common Stock Purchased NumberOfCommonStockPurchased	140000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023	LUCY	Number Of Common Stock Purchased NumberOfCommonStockPurchased	9188	shares
CY2023	us-gaap	Profit Loss ProfitLoss	-6663428	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5681833	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10515995	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6528959	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.63
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.87

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001829126-24-001847-index-headers.html	Edgar Link	pending
0001829126-24-001847-index.html	Edgar Link	pending
0001829126-24-001847.txt	Edgar Link	pending
0001829126-24-001847-xbrl.zip	Edgar Link	pending
ex23-1_001.jpg	Edgar Link	pending
ex23-1_002.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fin_001.jpg	Edgar Link	pending
fin_002.jpg	Edgar Link	pending
img_001.jpg	Edgar Link	pending
img_002.jpg	Edgar Link	pending
innovativeeye_ex19-1.htm	Edgar Link	pending
innovativeeye_ex23-1.htm	Edgar Link	pending
innovativeeye_ex31-1.htm	Edgar Link	pending
innovativeeye_ex31-2.htm	Edgar Link	pending
innovativeeye_ex32-1.htm	Edgar Link	pending
innovativeeye_ex32-2.htm	Edgar Link	pending
innovativeeye_ex4-7.htm	Edgar Link	pending
innovativeeye_ex97-1.htm	Edgar Link	pending
innovative_10k.htm	Edgar Link	pending
lucy-20231231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
lucy-20231231_cal.xml	Edgar Link	unprocessable
lucy-20231231_def.xml	Edgar Link	unprocessable
lucy-20231231_lab.xml	Edgar Link	unprocessable
innovative_10k_htm.xml	Edgar Link	completed
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
lucy-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LUCY
Innovative Eyewear Inc Stock $lucy

2024 Q1 Form 10-K Financial Statement

#000182912624001847 Filed on March 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUCY Innovative Eyewear Inc Stock $lucy

2024 Q1 Form 10-K Financial Statement

#000182912624001847 Filed on March 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUCY
Innovative Eyewear Inc Stock $lucy